Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepassocin Levels in Patients With Polycystic Ovary Syndrome

NCT04369248 is registered in ClinicalTrials.gov with Fatma ketenci gencer as lead sponsor.

NCT NCT04369248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04369248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepassocin Levels in Patients With Polycystic Ovary Syndrome
Lead sponsor
Fatma ketenci gencer
Phase
Observational
Overall status
Completed
Start date
January 3, 2020
Completion date
March 25, 2020
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepassocin (hepatocyte-derived fibrinogen-related protein 1), insulin resistance, obesity, polycystic ovary syndrome